Trials / Completed
CompletedNCT07445542
Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia
A Multi-center, Open-label, Observational Study to Evaluate the Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,927 (actual)
- Sponsor
- JW Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A Multi-center, Open-label, Observational Study to evaluate the Efficacy and Safety of Pitavastatin/Ezetimibe after switching from Statin Monotherapy to Pitavastatin/Ezetimibe in patients with Hypercholesterolemia
Detailed description
A Multi-center, Open-label, Observational Study
Conditions
Timeline
- Start date
- 2021-12-18
- Primary completion
- 2025-05-13
- Completion
- 2025-05-13
- First posted
- 2026-03-03
- Last updated
- 2026-03-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07445542. Inclusion in this directory is not an endorsement.